Oxford Biomedica plc announced that, after more than 13 years of service, John Dawson, Chief Executive Officer, has signalled to the Board his intention to retire from the company.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
345.9 GBX | +1.74% |
|
+0.70% | +57.24% |
17/07 | Oxford Biomedica plc Announces Board Changes, Effective from September 2, 2024 | CI |
17/07 | Oxford Biomedica Names New Finance Chief | MT |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+57.24% | 466M | |
+20.03% | 126B | |
+23.61% | 117B | |
+22.47% | 27.52B | |
-18.07% | 20.87B | |
-14.06% | 17.01B | |
-14.81% | 16.26B | |
+9.78% | 14.56B | |
-46.10% | 15.09B | |
+52.34% | 13.89B |
- Stock Market
- Equities
- OXB Stock
- News Oxford Biomedica plc
- Oxford Biomedica plc Announces Retirement of John Dawson as Chief Executive Officer